CANCER CENTER SUPPORT GRANT

癌症中心支持补助金

• 批准号: 6661825
• 负责人: WILLIAM N. HAIT
• 金额: $ 40万
• 依托单位: UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-04-06 至 2005-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6661825
• 关键词: biomedical facility; neoplasm /cancer

The Cancer Institute of New Jersey (CINJ) is a matrix style cancer center under the auspices of the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School. The Director serves as Associate Dean for Oncology Programs and is responsible for integrated research at the medical school with the Robert Wood Johnson University Hospital, the St. Peter's University Hospital, and several schools and departments of Rutgers University. CINJ was awarded its first P30 Cancer Support Grant (CA72720) on March 1, 1997. CINJ has 124 members, whose peer-reviewed, funded research projects, as defined by the CCSG guidelines, total more than $26.5 million in annual direct costs, over $6 million of which is from the NCI. The research base of CINJ is organized into seven programs: Cancer Pharmacology; Carcinogenesis and Chemoprevention; Molecular Mechanisms of Tumor Growth; Cytokines, Growth Factors, and Signal Transduction: Transcriptional Regulation and Oncogenesis; Clinical Investigations; and Cancer Control. With this application, CINJ has added programmatic strength in Population Science through two programs, Carcinogenesis and Chemoprevention, and Cancer Control. This application requests support for the following: Senior Leadership; Major Program Leaders; Planning and Evaluation; Developmental Funds; Administration; Clinical Protocol Scientific Review and Monitoring; and Protocol Specific Research. In addition, we are requesting funds for the following shared resources of CINJ: Analytical Cytometry; DNA Synthesis and Sequencing; Laboratory Support Services; Immunohistochemistry; Tissue Retrieval Service; Biometrics; Research Pharmacy; and Clinical Research Office.

新泽西癌症研究所(CINJ)是由新泽西医学和牙科大学罗伯特·伍德·约翰逊医学院赞助的母体式癌症中心。主任担任肿瘤学项目副院长，负责该医学院与罗伯特·伍德·约翰逊大学医院、圣彼得大学医院以及罗格斯大学的几个学院和系的综合研究。1997年3月1日，CINJ获得了其首个P30癌症支持补助金(CA72720)。CINJ有124名成员，根据CCSG指南的定义，其经同行审查、资助的研究项目每年的直接成本总计超过2650万美元，其中超过600万美元来自NCI。CINJ的研究基地由七个项目组成：癌症药理学；癌症发生和化学预防；肿瘤生长的分子机制；细胞因子、生长因子和信号转导：转录调节和肿瘤发生；临床研究；以及癌症控制。通过这一应用，CINJ通过两个项目--癌症发生和化学预防以及癌症控制--增加了人口科学的规划力量。此应用程序请求以下方面的支持：高级领导；主要项目负责人；规划和评估；发展基金；管理；临床方案科学审查和监测；以及方案具体研究。此外，我们正在为CINJ的以下共享资源申请资金：分析细胞学、DNA合成和测序、实验室支持服务、免疫组织化学、组织检索服务、生物计量学、研究药房和临床研究室。